Showing 13 of 13 recruiting trials for “eastern-equine-encephalitis”
Long-term Impact of NMDAR Encephalitis, Level 3
RecruitingNCT07477015 ↗
Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis
👨⚕️ Raffaele Iorio, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Jul 2025View details ↗
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)
RecruitingNCT07133113 ↗
Medium-term Effects of Treatments in Autoimmune Encephalitis
RecruitingNCT06019975 ↗
FDG-PET in the Diagnosis of Autoimmune Encephalitis
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
RecruitingNCT06173076 ↗
A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis
👨⚕️ Chun-Hong Shen, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China📍 1 site📅 Started May 2022View details ↗
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
RecruitingNCT05772611 ↗
Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes
Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
👨⚕️ Alasdair Coles, PhD FRCP, University of Cambridge, UK📍 10 sites📅 Started Nov 2017View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →